• Home
  • News and Stories
  • FDA Alert: Lannett Issues Voluntary Nationwide Recall of Levetiracetam Oral Solution 100 Mg Per ML

FDA Alert: Lannett Issues Voluntary Nationwide Recall of Levetiracetam Oral Solution 100 mg per mL

FDA Alert

Epilepsy News From: Friday, December 20, 2019

The U.S. Food and Drug Administration (FDA) issued an alert about liquid levetiracetam.

Two lots of Levetiracetam Oral Solution that is dispensed as 100 mg per mL (milligram per milliliter) have been voluntarily recalled by Lannett Company Inc. The lots of medicine were reportedly contaminated with a bacteria (called Bacillus subtilis) that is found in the environment. There is a low risk of serious infections if certain people are exposed to the contaminated product.

  • If you or a family member are taking liquid levetiracetam from the lots described in the FDA Alert, take the medicine to your pharmacist.
  • Contact your health care provider if you have any problems that may be related to taking or using this product.
  • For questions about this recall, contact Inmar at 866-255-4983 between Monday and Friday.
  • For general medical questions, contact the Lannett Medical Information Department at 844-834-0530 between Monday and Friday.

 

 

 

Authored by

Patty Obsorne Shafer RN, MN

Reviewed by

Elaine Wirrell MD

Reviewed Date

Friday, December 20, 2019

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.